Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

Clinical trial NCT05293665 · UNKNOWN

Trial details

NCT number: NCT05293665
Sponsor: Vaxxinity, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Vaccines

Start date: 2022-03-16
Primary completion: 2022-11-01
Enrollment: 944

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.